CRP and lymphopenia: Moreover, the COVID-19 patient exhibited improved values of numerous laboratory parameters, including biomarkers of inflammation (C-reactive protein from 389 to 24 mg/L; normal value: < 5); renal function (creatinine from 2.27 to 0.56 mg/dL; normal value: 0,59–1,29); coagulation (D-dimer from 3.83 to 0.82 mg/mL; normal value: < 0,25); respiratory function (Pa02/FiO2 from 86 to 234; normal value: > 300); and lymphopenia (from 0.6 to 1.48 × 109/L; normal value: 1,2–4.0) following UC-MSC treatment (Day 10) (Ciccocioppo et al., submitted for publication).